Loading...
Chemical structure of P110δ-IN-1

GC36832

P110δ-IN-1

Also known as N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-4-(2-methylsulfonylbenzimidazol-1-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine

P110δ-IN-1 is a potent and selective inhibitor of P110δ extracted from patent WO 2014055647 A1, with an IC50 of 8·4 nM

ChemicalCAS1595129-71-7MW604.77FormulaC31H40N8O3S
CAS number
1595129-71-7
Molecular weight
604.77
Formula
C31H40N8O3S
Solubility
DMSO： 20·83 mg/mL (34·44 mM); Water： ＜ 0·1 mg/mL (insoluble)
InChIKey
PGTXVGREXBMCCY-UHFFFAOYSA-N
Catalogue number
GC36832
Brand
GLPBIO
Computed properties PubChem CID 73441802 · XLogP 4.6 · TPSA 127 Ų · H-bond donors 1
XLogP
4.6
TPSA
127 Ų
H-bond donors
1
H-bond acceptors
10
Rotatable bonds
8
Heavy atoms
43

SMILES CC(C)(CC1=CC=CC=C1C2CCN(CC2)C)NC3=NC(=NC(=N3)N4CCOCC4)N5C6=CC=CC=C6N=C5S(=O)(=O)C

Computed descriptors from PubChem (CID 73441802), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.